Geneva, Oct. 15 -- International Clinical Trials Registry received information related to the study (ChiCTR2600134005) titled 'To compare the efficacy and safety of generic sugammadex sodium injection and original sugammadex sodium injection against steroid neuromuscular blockers in a randomized, double-blind controlled trial' on Oct. 10.
Study Type: Interventional study
Study Design:
Parallel
Primary Sponsor: Tianjin Medical University General Hospital
Condition:
Antagonistic steroid neuromuscular blocking agents
Intervention:
Experimental group (J group):Sugammadex sodium injection generic drug (Jianlisu) group
Recruitment Status: Not Recruiting
Phase: N/A
Date of First Enrollment: 2023-05-04
Target Sample Size: Experimen...